A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

Clinical trial NCT05890729 · RECRUITING

Trial details

NCT number: NCT05890729
Sponsor: Xentria, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pulmonary Sarcoidosis

Start date: 2023-11-10
Primary completion: 2029-05-01
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.